Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
19 Leser
Artikel bewerten:
(0)

Arcadia Resources Files $25 Million Shelf Registration Statement

INDIANAPOLIS, July 13 /PRNewswire-FirstCall/ -- Arcadia Resources, Inc. (NYSE Amex: KAD), a leading provider of innovative consumer health care services under the Arcadia HealthCare(SM) brand, today announced the filing of a shelf registration statement on Form S-3 with the Securities and Exchange Commission.

(Logo: http://photos.prnewswire.com/prnh/20100129/CG46351LOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20100129/CG46351LOGO)

The shelf registration statement, when declared effective by the SEC, will allow Arcadia the flexibility to potentially offer and sell from time to time in the future, in one or more public offerings, up to $25 million of common stock, warrants, senior debt securities and subordinated debt securities, or any combination thereof. The specifics of any future offering, along with the prices, terms, and the use of proceeds of any such securities offered by Arcadia will be determined at the time of any such offering and will be described in detail in a prospectus supplement filed at the time of any such offering.

"We consider this filing to be a proactive measure that will give Arcadia flexibility to access additional capital and will provide the opportunity to potentially move quickly into the capital markets over the next three years if needed," said Marvin R. Richardson, President and Chief Executive Officer of Arcadia HealthCare.

Arcadia's shelf registration statement has been filed with the SEC but has not yet become effective. The securities registered may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release does not constitute an offer to sell or the solicitation of an offer to buy the securities, nor shall there be any sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under securities laws of any such state or jurisdiction. An offering of the securities covered by the registration statement will only be by means of a written prospectus supplement

Copies of the prospectus included in the registration statement may be obtained on the SEC's website at http://www.sec.gov/ or by contacting Arcadia HealthCare, 9320 Priority Way West Drive, Indianapolis, IN 46240.

About Arcadia HealthCare(SM)

Arcadia HealthCare is a service mark of Arcadia Resources, Inc. (NYSE Amex: KAD), and is a leading provider of home care, medical staffing and pharmacy services under its proprietary DailyMed program. The Company, headquartered in Indianapolis, Indiana, has 70 locations in 18 states. Arcadia HealthCare's comprehensive solutions and business strategies support the Company's vision of "Keeping People at Home and Healthier Longer."

DailyMed(TM) Pharmacy dispenses a monthly cycle of a patient's prescriptions, over-the-counter medications and vitamins, and organizes them into pre-sorted packets clearly marked with the date and time the medications should be taken. In the dispensing process, a DailyMed pharmacist reviews each patient's medication profile and utilizes state-of-the-art medication therapy management tools to improve the safety and efficacy of the medications being dispensed. A DailyMed pharmacist provides routine communication with the patient, the primary care physician, caregivers and payers to maximize the pharmaceutical care administered. The DailyMed program improves patient care and drug utilization while reducing drug and hospitalization costs for private and government payers.

Forward-Looking Statements

This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.

Contact: Matthew Middendorf Chief Financial Officer mmiddendorf@arcadiahealthcare.com 317.569.8234 Bill Bunting In-Site Communications, Inc. (212) 759-3929 bbunting@insitecony.com

Photo: http://www.newscom.com/cgi-bin/prnh/20100129/CG46351LOGO
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk photodesk@prnewswire.com
http://photos.prnewswire.com/prnh/20100129/CG46351LOGO

Arcadia Resources, Inc.

CONTACT: Matthew Middendorf, Chief Financial Officer of Arcadia
Resources, Inc., +1-317-569-8234, mmiddendorf@arcadiahealthcare.com; or Bill
Bunting of In-Site Communications, Inc., +1-212-759-3929,
bbunting@insitecony.com, for Arcadia Resources, Inc.

Web Site: http://www.arcadiaresourcesinc.com/

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2010 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.